Resultados da busca - Anders Castor
- Mostrando 1 - 9 resultados de 9
-
1
Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and... por Linda Olsson, Anders Castor, Mikael Behrendtz, Andrea Biloglav, Erik Forestier, Kajsa Paulsson, Bertil Johansson
Publicado em 2013Artigo -
2
Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis por Miranda Buitenhuis, Liesbeth P. Verhagen, Hanneke W. M. van Deutekom, Anders Castor, Sandra Verploegen, Leo Koenderman, Sten Eirik W. Jacobsen, Paul J. Coffer
Publicado em 2007Artigo -
3
The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia por Kajsa Paulsson, Henrik Lilljebjörn, Andrea Biloglav, Linda Olsson, Marianne Rissler, Anders Castor, Gisela Barbany, Linda Fogelstrand, Ann Nordgren, Helene Sjögren, Thoas Fioretos, Bertil Johansson
Publicado em 2015Artigo -
4
Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia por Minjun Yang, Mattias Vesterlund, Ioannis Siavelis, Larissa Helena Moura‐Castro, Anders Castor, Thoas Fioretos, Rozbeh Jafari, Henrik Lilljebjörn, Duncan T. Odom, Linda Olsson, Naveen Ravi, E. L. Woodward, Louise Harewood, Janne Lehtiö, Kajsa Paulsson
Publicado em 2019Artigo -
5
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergro... por Andrea Biondi, Martin Schrappe, Paola De Lorenzo, Anders Castor, Giovanna Lucchini, Virginie Gandemer, Rob Pieters, Jan Starý, Gabriele Escherich, Myriam Campbell, Chi Kong Li, Ajay Vora, Maurizio Aricò, Silja Röttgers, Vaskar Saha, Maria Grazia Valsecchi
Publicado em 2012Artigo -
6
Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia por Christoph Lutz, Petter Woll, Georgina Hall, Anders Castor, Hélène Dreau, Giovanni Cazzaniga, Jan Zuna, C. E. Jensen, Sally A. Clark, Andrea Biondi, Chris Mitchell, Helen Ferry, Anna Schuh, Veronica J. Buckle, Sten Eirik W. Jacobsen, Tariq Enver
Publicado em 2012Carta -
7
Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia por Henrik Lilljebjörn, Rasmus Henningsson, Axel Hyrenius‐Wittsten, Linda Olsson, Christina Orsmark‐Pietras, Sofia von Palffy, Maria Askmyr, Marianne Rissler, Martin Schrappe, Gunnar Cario, Anders Castor, Cornelis Jan Pronk, Mikael Behrendtz, Felix Mitelman, Bertil Johansson, Kajsa Paulsson, Anna Andersson, Magnus Fontes, Thoas Fioretos
Publicado em 2016Artigo -
8
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial por Andrea Biondi, Virginie Gandemer, Paola De Lorenzo, Gunnar Cario, Myriam Campbell, Anders Castor, Rob Pieters, André Baruchel, Ajay Vora, Veronica Leoni, Jan Starý, Gabriele Escherich, Chi Kong Li, Giovanni Cazzaniga, Hélène Cavé, Jutta Bradtke, Valentino Conter, Vaskar Saha, Martin Schrappe, Maria Grazia Valsecchi
Publicado em 2018Artigo -
9
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-inducti... por Giovanni Cazzaniga, Paola De Lorenzo, Julia Alten, Silja Röttgers, Jeremy Hancock, Vaskar Saha, Anders Castor, Hans O. Madsen, Virginie Gandemer, Hélène Cavé, Veronica Leoni, Rolf Köhler, Giulia Ferrari, Kirsten Bleckmann, Rob Pieters, Vincent van der Velden, Jan Starý, Jan Zuna, Gabriele Escherich, Udo zur Stadt, Maurizio Aricò, Valentino Conter, Martin Schrappe, Maria Grazia Valsecchi, Andrea Biondi
Publicado em 2017Artigo
Ferramentas de busca:
Assuntos relacionados
Biology
Cancer research
Internal medicine
Medicine
Gene
Genetics
Leukemia
Oncology
Acute lymphocytic leukemia
Chromosomal translocation
Imatinib
Lymphoblastic Leukemia
Minimal residual disease
Myeloid leukemia
Chemotherapy
Environmental health
Immunology
Induction chemotherapy
Population
Surgery
Transplantation
Algorithm
CTCF
Cell biology
Chemotherapy regimen
Childhood leukaemia
Chromatin
Chromosomal rearrangement
Chromosome
Clinical endpoint